Kimberly-Clark completes acquisition of Kenvue, creating global consumer health and wellness leader
The combined company now includes 10 billion-dollar brands and serves consumers across multiple life stages and health needs
Kenvue
Kimberly-Clark appoints Suzana Blades as senior vice president and general counsel
Accomplished legal executive and global litigator brings proven track record of enterprise risk management and strategic leadership to support Kimberly-Clark's next chapter of growth.
Kimberly-Clark gears up for major Kenvue overhaul
The planned combination will streamline operations while creating a roughly $32 billion global health and wellness business.
FDA approves TYLENOL with Naproxen
FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.
JOHNSON’S Baby refreshes formulations to meet modern family needs
Key improvements across the reformulated portfolio focus on enhanced moisturization, soothing ingredients, and updated packaging.
Kenvue unveils new dermatology research and skin care innovations
New data and onsite activations reveal scientific advances in UV absorption technologies, lasting hydration, barrier supporting ingredients, and preferred acne solutions,
Neutrogena and OGX roll out new hair innovations
New NeutrogenavHair Restore and OGX ProGrowth + Peptide systems address need for accessible hair growth solutions.
Kenvue taps Jon Halvorson as new chief marketing officer
Company still battling claims from the Trump administration that its painkiller Tylenol is linked to autism.
retailmediaIQ hosts October 9 webcast on Medicare Advantage
This hour-long webcast features industry leaders from Kenvue, Kroger, and Soda Health.
Kenvue issues official company statement on Tylenol
"Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy."
Kenvue says it ‘strongly disagrees’ with Trump’s claims about acetaminophen
The FDA website says the agency has not found "clear evidence" that appropriate use of acetaminophen during pregnancy causes adverse pregnancy, birth, neurobehavioral, or developmental outcomes."
Medicare Advantage webcast: Retail and supplier insights
Explore new opportunities for retail and supplier collaboration in Medicare Advantage during this October 9 webcast.
Kenvue cuts 2025 outlook as analysts lower price targets
“Kenvue is clearly a ‘show me’ story” that must prove it can deliver steady improvement before the stock can regain momentum.”
LISTERINE partners with Cynthia Erivo on "Wash Your Mouth" campaign
Insures the iconic mouth of the award-winning actor, singer and cultural icon, to help reshape how people think about oral health.
Kirk Perry appointed interim CEO of Kenvue
The leadership change comes amid strategic uncertainty for Kenvue.
TYLENOL expands to proactive joint care with launch into the supplement category
The innovation is powered by a proprietary TamaFlex blend of turmeric and tamarind that is clinically shown to improve joint comfort, flexibility and function – in as early as five days.